Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy

Author： Abdel-Fatah Tarek   Albarakati Nada   Bowell Lara   Agarwal Devika   Moseley Paul   Hawkes Claire   Ball Graham   Chan Stephen   Ellis Ian   Madhusudan Srinivasan  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.3, 2013-12, pp. : 515-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Therapy of Breast Cancer

By Kaklamani Virginia   Gradishar William  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 548-560

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Therapy of Breast Cancer: An Overview

By Levitt Seymour H.   Kennedy B. J.  

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 403-409

Informa Healthcare

Access to resources Recommend Favorite

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

By Migliaccio Ilenia  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 651-660

Springer Publishing Company

Access to resources Recommend Favorite

Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer

By                          

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 121-130

Spandidos Publications

Access to resources Recommend Favorite

Vimentin DNA methylation predicts survival in breast cancer

By Ulirsch Jacob  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 383-396

Springer Publishing Company

Access to resources Recommend Favorite